Sergy Haut, France.
Pharmacol Res Perspect. 2021 Dec;9(6):e00861. doi: 10.1002/prp2.861.
Most but not all observational studies of statin treatment of COVID-19 patients suggest that treatment improves outcomes. However, almost all of these studies fail to consider that withdrawing statins after hospital admission may have detrimental effects, a finding which cardiovascular investigators have known for 15-20 years. Continuing or starting statin treatment after hospital admission consistently improves cardiovascular outcomes. Similarly, inpatient statin treatment of COVID-19 improves survival. For this reason, observational studies of the effectiveness of outpatient-documented statin treatment of COVID-19 patients must consider the negative consequences of statin withdrawal after hospital admission.
大多数（但不是全部）关于他汀类药物治疗 COVID-19 患者的观察性研究表明，治疗可以改善结局。然而，几乎所有这些研究都没有考虑到住院后停用他汀类药物可能会产生不利影响，心血管研究人员在 15-20 年前就已经知道这一发现。在住院后继续或开始他汀类药物治疗始终可以改善心血管结局。同样，住院期间用他汀类药物治疗 COVID-19 可以提高生存率。因此，对于 COVID-19 患者门诊记录的他汀类药物治疗效果的观察性研究，必须考虑住院后停用他汀类药物的负面影响。
